Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

Review of the Treatment of Mycosis Fungoides and Sézary Syndrome: A Stage-Based Approach

(2017) Steven M. Horwitz et al.   Journal of the National Comprehensive Cancer Network

Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sezary syndrome)

(2014) R. Dummer et al.   ANNALS OF ONCOLOGY

Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas

(2014) A. de Masson et al.   BRITISH JOURNAL OF DERMATOLOGY

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

(2014) Sarah I. Jawed et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) R. Willemze et al.   ANNALS OF ONCOLOGY

Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sezary syndrome

(2013) C. Querfeld et al.   BLOOD

Duration of Response in Cutaneous T-Cell Lymphoma Patients Treated With Denileukin Diftitox: Results From 3 Phase III Studies

(2013) Madeleine Duvic et al.   Clinical Lymphoma Myeloma & Leukemia

Prognostic factors and risk stratification in early mycosis fungoides

(2013) Eric C. Vonderheid et al.   LEUKEMIA & LYMPHOMA

How I treat prolymphocytic leukemia

(2012) C. Dearden   BLOOD

Management of indolent lymphoma: Where are we now and where are we going

(2012) Matthew A. Lunning et al.   BLOOD REVIEWS

Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sezary Syndrome from 1982 to 2009

(2012) R. Talpur et al.   CLINICAL CANCER RESEARCH

Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study

(2012) Francine Foss et al.   Clinical Lymphoma Myeloma & Leukemia

Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma: A systematic review

(2012) M. Schlaak et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial

(2012) Madeleine Duvic et al.   EUROPEAN JOURNAL OF CANCER

Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012

(2012) Reinhard Dummer et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel therapeutic agents for cutaneous T-Cell lymphoma

(2012) Salvia Jain et al.   Journal of Hematology & Oncology

Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis

(2012) Robert Knobler et al.   PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

(2011) Elise A. Olsen et al.   JOURNAL OF CLINICAL ONCOLOGY

Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone

(2010) J.-L. Harousseau et al.   BLOOD

Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

(2010) Rafael F. Duarte et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients With Cutaneous T-Cell Lymphoma

(2010) H. Miles Prince et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal

(2010) Nita Sally Agar et al.   JOURNAL OF CLINICAL ONCOLOGY

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

(2010) Sean J. Whittaker et al.   JOURNAL OF CLINICAL ONCOLOGY

Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center

(2010) Christiane Querfeld et al.   LEUKEMIA & LYMPHOMA

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome

(2009) P. L. Zinzani et al.   ANNALS OF ONCOLOGY

How I treat mycosis fungoides and Sezary syndrome

(2009) H. M. Prince et al.   BLOOD

Bexarotene therapy for mycosis fungoides and Sézary syndrome

(2009) R.A. Abbott et al.   BRITISH JOURNAL OF DERMATOLOGY

Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors

(2009) H Miles Prince et al.   Future Oncology

Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation

(2008) S. O. Arulogun et al.   BLOOD

Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma

(2008) R F Duarte et al.   BONE MARROW TRANSPLANTATION